Luis Montuenga Badía

22PUBLICATIONS
118CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Oncology and carcinogenesis not elsewhere classifiedInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 27, 2026
Loss of PTEN as an Independent Poor Prognosis Indicator in Lung Adenocarcinoma, but Not in Squamous Cell Carcinoma, Is Associated with an Immunosuppressive Tumor Microenvironment and Distinct Co-Mutational Profiles.

|Jan 16, 2026
NOTCH1 intracellular domain stabilization by MDM2 plays a major role in NSCLC response to platinum.

Sara Bernardo, Lisa Brunet, Quentin Dominique Thomas

|Jul 25, 2025
Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy.

Esther Redin, Nerea Otegui, Mirentxu Santos

|Feb 24, 2024
Oxidative Damage and Telomere Length as Markers of Lung Cancer Development among Chronic Obstructive Pulmonary Disease (COPD) Smokers.

Elizabeth Córdoba-Lanús, Luis M Montuenga, Angélica Domínguez-de-Barros

|Aug 07, 2023
Estrogen Receptor and Immune Checkpoint Inhibitors: New Partners in Lung Cancer?

Karmele Valencia, Luis M Montuenga, Alfonso Calvo

|Jun 28, 2023
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer.

Nerea Otegui, Maeva Houry, Imanol Arozarena

Pageof 4

Frequent Collaborators

8 joint publications

Alfonso Calvo

7 joint publications

Karmele Valencia

5 joint publications

Francisco Exposito

4 joint publications

Irati Garmendia